Prospective study of tansarterial embolization for hepatocellular carcinoma with Lipiodol added Lecithin.
Phase 3
- Conditions
- hepatocellar carcinoma
- Registration Number
- JPRN-UMIN000004312
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1:The patient with the anamnesis of the drug hypersensitivity. 2:The patient with contraindication of medication(Hydrochloric acid doxorubicin, Lipiodol, Gelpert and lecithin). 3:The patient with contraindication of TAE. a.Severe liver failure b.Serum Bilirubin(T-Bil):T-Bil>3mg/dl c.Large quantities of acites. 4:The patient having the activity-related infectious disease(more than fever 38.0 degrees ).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method curative effect,response rate,survival time, survival rate
- Secondary Outcome Measures
Name Time Method adverse events